project id: TCGA-UCEC; case submitter id: TCGA-A5-AB3J; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.5; age at index: 52; days to birth: -19020; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1961; age at diagnosis: 19020; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 512.0; figo stage: Stage II; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: Not Reported; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 126; days to sample procurement: 0; initial weight: 210.0; portion submitter id: TCGA-A5-AB3J-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 10.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;